In 2026, one of the most alarming product liability cases in recent memory continues to unfold across courtrooms nationwide. The contaminated eye drops lawsuit involving EzriCare Artificial Tears has moved into a critical phase, with settlement negotiations actively underway and attorneys still accepting new clients. If you or someone you love used EzriCare or Delsam Pharma artificial tears and experienced a serious eye infection, vision loss, or worse, what happens in the coming months could directly affect your ability to recover compensation. Here is everything injured victims need to know right now.
What Happened: The EzriCare Contamination Crisis
The crisis began when the U.S. Food and Drug Administration issued a sweeping recall of EzriCare Artificial Tears and Delsam Pharma Artificial Tears in February 2026 — the culmination of an investigation into products manufactured by Global Pharma Healthcare, an India-based company. Laboratory testing confirmed the presence of Pseudomonas aeruginosa, specifically a carbapenem-resistant strain known as CRPA, one of the most dangerous and drug-resistant bacteria that can infect the human eye.
The contamination was not a minor quality-control lapse. According to the Centers for Disease Control and Prevention, investigators identified more than 81 infections spanning 18 states, resulting in 4 deaths and at least 4 cases requiring surgical eye removal — a procedure known medically as enucleation. These are not statistics. These are real people who trusted an over-the-counter product to soothe dry eyes and instead suffered life-altering or fatal consequences.
The lawsuits that followed allege that Global Pharma Healthcare, as well as distributors and retailers who sold the product, engaged in negligent manufacturing practices, failed to adequately test for contamination, and violated FDA Current Good Manufacturing Practice (CGMP) regulations — including the use of multi-dose bottles without preservatives, a practice that significantly increases bacterial contamination risk. The contaminated eye drops lawsuit wave officially began in May 2026 and continues to grow.
Documented Injuries: What the FDA and CDC Data Reveals
The scope of harm tied to this product is severe, and the documented injury profile is central to understanding why this litigation carries such significant compensation potential. Victims have reported a wide spectrum of injuries, ranging from painful corneal ulcers to permanent blindness to death from sepsis — a systemic infection caused by bacteria entering the bloodstream.
| Injury Category | Documented Cases | Source |
|---|---|---|
| Total CRPA Infections Identified | 81+ across 18 states | CDC Investigation |
| Deaths Attributed to Contamination | 4 confirmed | CDC/FDA Joint Investigation |
| Enucleations (Surgical Eye Removal) | 4 confirmed | CDC/FDA Joint Investigation |
| Vision Loss Cases | Multiple reported | FDA Adverse Event Reports |
| Corneal Ulcers / Severe Infections | Numerous reported | FDA MedWatch Database |
The injuries documented in these cases are among the most catastrophic seen in a consumer product contamination case in years. Pseudomonas aeruginosa eye infections are notoriously resistant to standard antibiotics, meaning that even patients who received prompt medical care often faced irreversible damage. Under product liability law, manufacturers have a legal duty to ensure their products are safe for intended use — and the evidence suggests Global Pharma Healthcare failed that duty entirely.
2026 Litigation Status: Where the Cases Stand Right Now
As of June 2026, the contaminated eye drops lawsuit landscape is at a pivotal juncture. Unlike some large-scale product liability actions that quickly consolidate into a single federal Multi-District Litigation (MDL), these cases have not yet been centralized under MDL management. That means individual lawsuits are being filed and litigated on separate tracks — and settlement negotiations are happening without the unified structure that an MDL provides.
This decentralized status has important implications for plaintiffs. On one hand, it means that early movers — those who file claims now — may have more leverage in individual settlement negotiations before a global deal is reached. On the other hand, without MDL consolidation, injured victims who wait too long risk missing critical deadlines or being left out of favorable settlement structures entirely. Justia’s product liability overview explains how these individual filing timelines interact with broader litigation strategies in mass tort cases.
Multiple law firms across the country are actively accepting new contaminated eye drops lawsuit cases as of June 2026, and reports indicate that settlement talks between plaintiffs’ counsel and defendants are underway. The combination of catastrophic documented injuries, clear regulatory violations, and FDA-confirmed contamination makes this litigation particularly strong from a liability standpoint — and potentially very valuable for severely injured claimants.
Who Can File a Contaminated Eye Drops Lawsuit in 2026
You may be eligible to file a contaminated eye drops lawsuit if you used EzriCare Artificial Tears or Delsam Pharma Artificial Tears and subsequently developed any of the following conditions: a Pseudomonas aeruginosa eye infection, corneal ulcers, permanent vision loss or blindness, the need for surgical eye removal (enucleation), systemic infection or sepsis, or if you lost a loved one to complications tied to the contaminated product.
Eligibility is not limited to people who purchased the product directly. Many victims received EzriCare drops through healthcare facilities, pharmacies, or as free samples — and they still have valid legal claims. The key elements that attorneys evaluate include: confirmed or probable use of the recalled product, a documented medical diagnosis consistent with Pseudomonas aeruginosa infection or related complications, and injury occurring within a timeframe consistent with product use.
Families who lost loved ones to sepsis or other fatal complications tied to the contaminated drops may also have standing to pursue wrongful death claims. If you are evaluating what a wrongful death claim might be worth, a wrongful death calculator can help you understand the general range of compensation categories typically considered in these cases, including loss of income, loss of companionship, and funeral expenses.
What Compensation May Be Available to Victims
The compensation available in a contaminated eye drops lawsuit depends heavily on the severity of the injury. Cases involving permanent blindness, enucleation, or death are the highest-value claims in this litigation — and attorneys handling these cases are pursuing both economic and non-economic damages on behalf of their clients.
Economic damages typically include medical expenses (past and future), lost wages and earning capacity, costs of ongoing care, and out-of-pocket expenses related to the injury. Non-economic damages — often the largest component in catastrophic injury cases — include pain and suffering, emotional distress, loss of enjoyment of life, and disfigurement. For victims who had an eye surgically removed or who are permanently blind, non-economic damages alone can be substantial.
To get a general sense of what your claim might be worth based on injury type and documented losses, you can use a personal injury settlement calculator as a starting point. Keep in mind that no tool replaces the analysis of an experienced personal injury attorney who can evaluate the specific facts of your case, your medical records, and the ongoing settlement dynamics in this litigation.
Punitive damages may also be on the table in some cases. When a manufacturer’s conduct is found to be grossly negligent — and using multi-dose eye drop bottles without preservatives in clear violation of FDA CGMP regulations arguably clears that bar — courts can award additional damages designed to punish the defendant and deter similar conduct. Nolo’s guide to punitive damages provides a helpful overview of when and how these awards are calculated.
Critical Deadlines: Why Filing Now Matters
One of the most consequential decisions any injured victim can make is waiting too long to consult an attorney. Every state imposes a statute of limitations on personal injury and wrongful death claims — these are strict legal deadlines that, once missed, permanently bar you from recovering compensation regardless of how strong your case might be. In most states, the window for personal injury claims is two to three years from the date of injury or discovery of harm, but these timelines vary significantly.
Because the EzriCare contaminated eye drops lawsuit cases are not yet consolidated into an MDL, there is no court-imposed global stay on statutes of limitations. That means your individual deadline is running right now, independently of what happens in other plaintiffs’ cases. Acting quickly also positions you for early settlement consideration — attorneys report that defendants in mass tort cases often resolve the highest-value claims first, particularly those with the most severe and well-documented injuries.
Frequently Asked Questions About the EzriCare Contaminated Eye Drops Lawsuit
What eye drop products are included in the contaminated eye drops lawsuit?
The primary products at the center of this litigation are EzriCare Artificial Tears and Delsam Pharma Artificial Tears, both manufactured by Global Pharma Healthcare. These products were subject to an FDA recall due to confirmed contamination with carbapenem-resistant Pseudomonas aeruginosa (CRPA). If you used either of these products and developed an eye infection or related injury, you may have a valid claim regardless of whether you still have the product in your possession.
How serious are the injuries associated with this contaminated eye drops lawsuit?
The injuries documented in connection with this litigation are among the most severe seen in a consumer product case in recent years. The CDC confirmed 81 or more infections across 18 states, including 4 deaths and 4 cases requiring surgical eye removal (enucleation). Additional victims have suffered permanent vision loss, corneal ulcers, and systemic infections. The carbapenem-resistant strain of Pseudomonas aeruginosa is notoriously difficult to treat, and many victims experienced irreversible harm despite prompt medical intervention.
Is there a class action or MDL for the contaminated eye drops lawsuit?
As of June 2026, the EzriCare contaminated eye drops cases have not been consolidated into a Multi-District Litigation (MDL). Individual lawsuits are being filed and litigated separately across multiple jurisdictions, and settlement negotiations are underway without centralized MDL management. This makes it especially important for injured victims to consult with an attorney promptly, as individual case deadlines apply and early settlement positioning may benefit those who act now.
How much compensation can victims recover in the contaminated eye drops lawsuit?
Compensation varies based on the nature and severity of your injury. Victims with catastrophic injuries — including permanent blindness, surgical eye removal, or death from sepsis — are likely to have the highest-value claims. Recoverable damages may include medical expenses, lost wages, future care costs, pain and suffering, emotional distress, and potentially punitive damages given the nature of the manufacturing violations alleged. An attorney can evaluate the specific facts of your situation to provide a realistic assessment of your claim’s value.
What do I need to prove to file a contaminated eye drops lawsuit?
To build a successful claim, your attorney will generally need to establish that you used EzriCare or Delsam Pharma Artificial Tears, that you developed a Pseudomonas aeruginosa infection or related injury, and that a causal link exists between your use of the product and your harm. Medical records documenting your diagnosis, treatment, and ongoing effects are critical. Even if you no longer have the product itself, purchase receipts, prescription records, or pharmacy records showing you obtained the product can support your claim. An experienced personal injury attorney can help you gather and preserve the evidence needed to file.
Legal Disclaimer: The information provided in this article is for general informational purposes only and does not constitute legal advice or establish an attorney-client relationship; consult a qualified personal injury attorney for guidance specific to your situation.
Related reading: Pressure Cooker Burn Injury Lawsuit: Verdict & Damages When Lids Fail Under Pressure
Thomas B. Harrison is a personal injury legal consultant with extensive experience connecting injury victims with qualified attorneys across the United States. He specializes in helping people understand when they need legal representation and how to find the right personal injury attorney for their specific situation. Thomas is not an attorney and the information he provides is for educational purposes only.